Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NIOX GROUP PLC Director's Dealing 2026

Apr 1, 2026

7814_dirs_2026-04-01_20ba1f40-734e-48e2-87b3-c7be7f8d81c4.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9196Y

Niox Group PLC

01 April 2026

NIOX Group plc

("NIOX" or the "Company")

Director/PDMR Shareholding and Total Voting Rights

1 April 2026

NIOX Group plc (AIM: NIOX) announces that on 31 March 2026 it issued 135,188 new ordinary shares in the Company ("Ordinary Shares") to Jonathan Emms, Chief Executive Officer, under the Company's Deferred Share Bonus Plan (the "Plan").

The share issue was made in respect of the annual bonus for the 2023 financial year, which was granted on 20 March 2024. Under the terms of the Company's remuneration policy, 25% of this bonus was paid in shares at that time, with the remaining 75% of this bonus deferred for two years, other than for the sale of shares to satisfy any tax liability created on grant.

The 135,188 new Ordinary Shares issued in connection with this award are subject to an existing block admission for the respective Plan and rank pari passu with the Company's existing Ordinary Shares.

Following this allotment, Jonathan Emms' interest in the Company is as follows:

Number of Ordinary Shares issued Resulting number of Ordinary Shares held Resulting interest in the Company
Jonathan Emms 135,188 3,399,076 0.813%

Total voting rights

Following the above share issue, the Company's issued share capital comprises 418,074,453 Ordinary Shares, each carrying one voting right. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Additional details are provided below in accordance with the requirements of UK MAR.

For further information, please contact:
NIOX Group plc

Jonathan Emms, Chief Executive Officer

Sarah Duncan, Chief Financial Officer

Rebecca Clayton-Wherity, Company Secretary
+44 (0) 3303 309 356
Singer Capital Markets (Nominated Adviser and Broker)

Jen Boorer / James Fischer
+44 (0) 20 7496 3000

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Jonathan Emms

2.  

Reason for the notification

a.         

Position/status

Chief Executive Officer

b.         

Initial notification

/Amendment

Initial notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

NIOX Group plc

b.         

LEI

2138006YAT138TOGA556

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

GB00BJVD3B28

b.         

Nature of the transaction

Issue of new Ordinary Shares under the Deferred Share Bonus Plan

c.         

Price(s) and volume(s)

Price(s) Volume(s)
0.08p 135,188

d.         

Aggregated information

·      Aggregated volume

·      Price

n/a

e.         

Date of the transaction

31/03/2026

f.         

Place of the transaction

London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFIRVEILVIR